Young Professor
05-08-2008, 08:23 PM
Cephalon presented to the FDA on Monday re: a label expansion for Fentora. Currently, it's only approved for cancer pain, although Docs can write for other conditions. Cephalon is looking for a much wider label, especially for back pain. They want to detail to a wide range of Docs.
http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4356b2-02-Cephalon.pdf
YP
http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4356b2-02-Cephalon.pdf
YP